Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1879

1.

Upper gastrointestinal hemorrhage and thoracic aortic aneurysm rupture as presenting signs of Behçet disease: A case report.

Yu LF, Guo LW, He JP, Yang B, Chen CH, Jin J.

Medicine (Baltimore). 2019 Oct;98(41):e17455. doi: 10.1097/MD.0000000000017455.

2.

Clinical and Radiographic Characteristics of Neuro-Behçet's Disease in South Korea.

Kim SW, Kim TG, Oh J, Kim DY, Choi YC, Kim SM, Shin HY, Bang D.

J Clin Neurol. 2019 Oct;15(4):429-437. doi: 10.3988/jcn.2019.15.4.429.

3.

Inhibition of CD83 Alleviates Systemic Inflammation in Herpes Simplex Virus Type 1-Induced Behçet's Disease Model Mouse.

Islam SMS, Byun HO, Choi B, Sohn S.

Mediators Inflamm. 2019 Sep 9;2019:5761392. doi: 10.1155/2019/5761392. eCollection 2019.

4.

Lymphocyte proliferation induced by high-affinity peptides for HLA-B*51:01 in Behçet's uveitis.

Kaburaki T, Nakahara H, Tanaka R, Okinaga K, Kawashima H, Hamasaki Y, Rungrotmongkol T, Hannongbua S, Noguchi H, Aihara M, Takeuchi F.

PLoS One. 2019 Sep 12;14(9):e0222384. doi: 10.1371/journal.pone.0222384. eCollection 2019.

5.

Associations of Mitochondrial Deoxyribonucleic Acid Polymorphisms With Behçet's Disease in the Korean Population.

Kwon M, Yoo SJ, Yoo IS, Kim J, Kang SW, Choi IA, Lim MK, Joung CI.

Arch Rheumatol. 2019 Jan 28;34(2):211-219. doi: 10.5606/ArchRheumatol.2019.7113. eCollection 2019 Jun.

6.

[Epidemiological, clinical, therapeutic and evolutionary profile of ocular manifestations in patients with Behçet's disease].

Razzak A, Kassimi A, Mchachi A, Benhmidoune L, Chakib A, Rachid R, Elbelhadji M, Amraoui A, Elkabli H.

Pan Afr Med J. 2019 Jun 14;33:116. doi: 10.11604/pamj.2019.33.116.17111. eCollection 2019. French.

7.

Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behçet's Disease.

Ugurel E, Erdag E, Kucukali CI, Olcay A, Sanli E, Akbayir E, Kurtuncu M, Gunduz T, Yilmaz V, Tuzun E, Vural B.

In Vivo. 2019 Sep-Oct;33(5):1493-1497. doi: 10.21873/invivo.11629.

8.

An unusual case of Behcet disease with posterior scleritis: A case report.

Yanagida C, Usui Y, Sakai JI, Goto H.

Medicine (Baltimore). 2019 Aug;98(35):e16886. doi: 10.1097/MD.0000000000016886.

9.

Acute myeloid leukemia in a young male patient with Behçet's disease presenting with febrile neutropenia.

Sharma A, Ali M, Chauhan S, Singh S, Arya V.

Reumatologia. 2019;57(3):178-181. doi: 10.5114/reum.2019.86430. Epub 2019 Jun 28.

10.

Trisomy-8-Positive Hematologic Malignancies Associated with Intestinal Behçet's Syndrome: Keep This Entity in Mind.

Salihoglu A, Soysal T.

Acta Haematol. 2019 Aug 27:1-2. doi: 10.1159/000501841. [Epub ahead of print] No abstract available.

11.

Proteomics-based functional studies reveal that galectin-3 plays a protective role in the pathogenesis of intestinal Behçet's disease.

Lee HJ, Kim JH, Hong S, Hwang I, Park SJ, Kim TI, Kim WH, Yu JW, Kim SW, Cheon JH.

Sci Rep. 2019 Aug 12;9(1):11716. doi: 10.1038/s41598-019-48291-1.

12.

KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behçet Disease.

Petrushkin H, Norman PJ, Lougee E, Parham P, Wallace GR, Stanford MR, Fortune F.

J Immunol. 2019 Sep 15;203(6):1629-1635. doi: 10.4049/jimmunol.1801178. Epub 2019 Aug 12.

13.

Evaluation of Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio in patients with Behçet's disease.

Hidayet Ş, Demir V, Turan Y, Gürel G, Taşolar MH.

Anatol J Cardiol. 2019 Aug;22(2):85-90. doi: 10.14744/AnatolJCardiol.2019.70019.

14.

Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet's disease-related uveitis.

Ho M, Chen LJ, Sin HPY, Iu LPL, Brelen M, Ho ACH, Lai TYY, Young AL.

J Ophthalmic Inflamm Infect. 2019 Jul 31;9(1):14. doi: 10.1186/s12348-019-0181-z.

15.

High levels of endothelial progenitor cells and circulating endothelial cells in patients with Behçet's disease and their relationship to disease activity.

Arica DA, Akşan B, Örem A, Altinkaynak BA, Yayli S, Sönmez M.

An Bras Dermatol. 2019 Jul 29;94(3):320-326. doi: 10.1590/abd1806-4841.20198169.

16.

Endovascular treatment for Behçet's disease: a case report.

Belczak SQ, da Silva IT, Marques GG, Copetti LF, Stefaniak V, Quintas GG, Uchimura KB.

J Vasc Bras. 2019 Jun 8;18:e20180121. doi: 10.1590/1677-5449.180121.

17.

Leptospiral presentation in Behçet's disease: A case report.

Chen TL, Wang LS.

J Formos Med Assoc. 2019 Jul 25. pii: S0929-6646(19)30407-3. doi: 10.1016/j.jfma.2019.07.005. [Epub ahead of print] No abstract available.

18.

[Behçet syndrome].

López-García S, Vizán-Caravaca JR, García-Castro JM.

Aten Primaria. 2019 Jul 24. pii: S0212-6567(19)30295-1. doi: 10.1016/j.aprim.2019.05.013. [Epub ahead of print] Spanish. No abstract available.

19.

MICA*049, not MICA*009, is associated with Behçet's disease in a Chinese population.

Zhu W, Deng Y, Wang J, Guo X, Ding W, Chao J, Lin D, Wang Y, Zhou X.

Sci Rep. 2019 Jul 26;9(1):10856. doi: 10.1038/s41598-019-47289-z.

20.

Single Nucleotide Polymorphisms of FCRL3 in Iranian Patients with Behcet's Disease.

Shahram F, Kazemi J, Mahmoudi M, Jadali Z.

Iran J Public Health. 2019 Jun;48(6):1133-1139.

Supplemental Content

Loading ...
Support Center